Screening for NPC.
This paper discusses the criteria of cancer screening in general and of nasopharyngeal carcinoma in particular. It also discusses the screening results in China and the strategy for screening of this cancer in Singapore.
Chan
S H
SH
WHO Immunology Centre, Faculty of Medicine, Singapore.
D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000276:immunology; D002213:Capsid / Q000276:immunology; D036022:Capsid Proteins; D002681:China; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D009303:Nasopharyngeal Neoplasms / Q000453:epidemiology*; D011237:Predictive Value of Tests; D012846:Singapore
D000914:Antibodies, Viral; D000956:Antigens, Viral; D036022:Capsid Proteins; C041788:Epstein-Barr viral capsid antigen; C033305:Epstein-Barr virus early antigen